# A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma

> **NCT07309614** · PHASE3 · RECRUITING · sponsor: **Université de Sherbrooke** · enrollment: 150 (estimated)

## Conditions studied

- Asthma Control

## Interventions

- **DRUG:** Dupilumab Prefilled Syringe
- **DRUG:** Placebo Injection

## Key facts

- **NCT ID:** NCT07309614
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-29
- **Primary completion:** 2029-01
- **Final completion:** 2030-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07309614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07309614, "A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07309614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*